AB Sagax (publ) has held its Annual General Meeting on 8 May 2025.

Appropriation of retained earnings and discharge from liability
The Annual General Meeting adopted the income statement and the balance sheet as well as the Board of Directors’ proposal on appropriation of retained earnings. The Annual General Meeting also adopted the Board of Directors’ proposal for dividend to the shareholders of SEK 3.50 per ordinary share of series A and series B and on a dividend to the shareholders of SEK 2.00 per ordinary share of series D for the financial year 2024, with a quarterly payment of SEK 0.50 per ordinary share of series D. The record date for receiving dividend for the ordinary shares of series A and series B is Monday 12 May 2025. The record dates for receiving dividend for the ordinary shares of series D is Monday 30 June 2025, Tuesday 30 September 2025, Tuesday 30 December 2025 and Tuesday 31 March 2026. The dividend is expected to be distributed by Euroclear on the third weekday after each record date.

The Annual General Meeting also resolved that the new ordinary shares of series D that may be issued with the support of the Annual General Meeting’s authorisation shall entitle to dividends from the date they have been entered in the share register kept by Euroclear.

The Annual General Meeting also discharged the Board members and the CEO from liability for the financial year 2024.

Election of Board members
The Annual General Meeting resolved that the number of Board members shall amount to six for the period until the next Annual General Meeting. The Annual General Meeting also resolved to re-elect the Board members Johan Cederlund, Filip Engelbert, David Mindus, Staffan Salén, Johan Thorell and Ulrika Werdelin. Staffan Salén was elected as the chairperson of the Board of Directors. The Annual General Meeting resolved on fees of SEK 400,000 to the chairperson of the Board of Directors and SEK 220,000 to each other non-executive Board members elected by the Annual General Meeting. The fees include remuneration for committee work. The resolution was in accordance with the Nomination Committee’s proposal.

Election of auditors
The Annual General Meeting resolved to re-elect the registered public accounting firm Ernst & Young Aktiebolag for the period until the end of the next Annual General Meeting. It is Ernst & Young Aktiebolag’s intention to appoint Jonas Svensson as auditor in charge. The fee to the auditor shall be paid according to approved invoice. The resolution was in accordance with the Nomination Committee’s proposal and the Audit Committee’s recommendation.

Remuneration Report 2024
The Annual General Meeting resolved to approve the Board of Directors’ Remuneration Report for 2024 in accordance with Chapter 8, Section 53 a of the Swedish Companies Act.

Incentive Program 2025/2028
The Annual General Meeting resolved on the introduction of an incentive program through an issue of a maximum of 700,000 warrant of series 2025/2028. The subscription right shall, with deviation from the shareholders’ preferential rights, belong to the wholly owned subsidiary Satrap Kapitalförvaltning AB. Each warrant shall entitle the holder to subscribe for one new ordinary share of series B in AB Sagax during the period from and including 31 May 2028 to and including 13 June 2028. The Annual General Meeting also resolved to approve that Satrap Kapitalförvaltning AB may transfer a maximum of 700,000 warrants in AB Sagax of series 2025/2028 to employees, or otherwise dispose of the warrants to secure the commitments under the Incentive Program 2025/2028. Each employee shall be offered to acquire warrants in an amount corresponding to a maximum of one twelfth (1/12) of the employee’s annual salary before income tax. The warrants shall be offered to employees at a price corresponding to an estimated market value for the warrants. The maximum number of additional ordinary shares of series B are estimated to a maximum of 700,000, which corresponds to approximately 0.21 percent of the total number of ordinary shares of series A and B in the company (excluding the company’s own holding of ordinary shares of series B), provided full subscription and full exercise of all warrants. In such case, the increase in the share capital will amount to a maximum of SEK 1,225,000. The incentive program is aimed to persons who are or become employed by AB Sagax or its subsidiaries. The CEO of the company is not covered by the program. The resolution was in accordance with the Board of Directors’ proposal.

Authorisation for the Board of Directors
The Annual General Meeting resolved to authorise the Board of Directors to, within the framework of the current Articles of Association, with or without deviation from the shareholders’ preferential rights, on one or more occasions until the next Annual General Meeting, resolve on an increase in the company’s share capital through a new issue of ordinary share of series A, ordinary shares of series B, ordinary shares of series D, warrants and/or convertibles in the company. The total number of shares covered by such issues may correspond to a total of no more than ten percent of the share capital in the company, based on the share capital in the company at the time when the Board of Director first exercises the authorisation. The issues shall be made at a market price, subject to a market discount if applicable, and payment may, in addition to cash payment, be made by contribution in kind or by way of set-off, or otherwise with conditions. The resolution was in accordance with the Board of Directors’ proposal.

The Annual General Meeting also resolved to authorise the Board of Directors to, on one or more occasions until the next Annual General Meeting, resolve on the acquisition of a total of so many ordinary shares of series A, ordinary shares of series B, ordinary shares of series D, warrants and/or convertibles that the company’s own holding at any given time do not exceed one tenth of all shares in the company. Acquisition of own shares shall take place on Nasdaq Stockholm and may only take place at a price within the price interval applicable at any given time, by which is imply the interval between the highest purchase price and lowest selling price, or through an acquisition offer addressed to all shareholders, whereby the acquisition shall take place at a price which at the time of the resolution corresponds to not less than applicable share price and a maximum of 150 percent of the applicable stock exchange price. Acquisition of own warrants and/or convertibles shall take place at a price that at the time of the decision corresponds to not more than market value. The resolution was in accordance with the Board of Directors’ proposal.

Further, the Annual General Meeting resolved to authorise the Board of Directors to, on one or more occasions until the next Annual General Meeting, resolve on transfer, with or without deviation from the shareholders’ preferential rights, of all or parts of the company’s own holding of ordinary shares of series A, ordinary shares of series B, ordinary shares of series D, and/or warrants as payment in connection with acquisitions of properties or real estate companies, or part of properties or real estate companies, at a price corresponding to the share price, or in the case of warrants, the market value at the time of the transfer. Transfer of all or parts of the company’s own holding of ordinary shares of series A, ordinary shares of series B, ordinary shares of series D may also take place, on one or more occasions until the next Annual General Meeting, to finance such acquisitions, alternatively to finance general business purposes, whereby the sale of shares shall take place on Nasdaq Stockholm at a price within the price range applicable at any given time. The resolution was in accordance with the Board of Directors’ proposal.